Further analysis showed that ASCL1 knockdown resulted in the downregulation of the ATP-binding cassette transporter (ABCG2), a protein linked to drug resistance in BC, also known as the breast cancer resistance protein (31) (Figure 6O). Here, ASCL1 is linked to breast cancer.